Home › Funds › NVP Associates, LLC › AVLN

NVP Associates, LLC position in AVLN

AVALYN PHARMACEUTICALS INC · Health Care

NVP Associates, LLC reported holding 2,268,404 shares of AVLN (AVALYN PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$64.6M, representing 22.92% of its reported portfolio and ranking #2 among its reported holdings. NVP Associates, LLC has disclosed AVLN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)2.27M sh
Reported value held$64.63M
Portfolio Weight22.92%
First reportedQ2 2026
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How NVP Associates, LLC's AVLN position evolved

NVP Associates, LLC first disclosed a stake in AVLN in Q2 2026 at 2,268,404 shares (US$74.7M). Across 2 filings, NVP Associates, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,268,404 shares valued at US$64.6M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 2.27M $74.68M New
Q3 2026 2.27M $64.63M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVLN and 13F data

AVLN (AVALYN PHARMACEUTICALS INC) is a Health Care company. 113 other funds we track also report a position in AVLN — the largest reported positions include Novo Holdings A/S (US$127.8M), SR ONE CAPITAL MANAGEMENT, LP (US$108.9M), PERCEPTIVE ADVISORS LLC (US$88.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVLN

All AVLN fund holders →

FAQ

How long has NVP Associates, LLC held AVLN?

NVP Associates, LLC has disclosed AVLN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is NVP Associates, LLC's current position in AVLN?

As of Q3 2026, NVP Associates, LLC holds 2.27M shares of AVLN (AVALYN PHARMACEUTICALS INC), valued at $64.63M, representing 22.92% of its reported portfolio and ranking #2.

Has NVP Associates, LLC been buying or selling AVLN?

In the latest 13F filing (Q3 2026), NVP Associates, LLC held unchanged its position in AVLN.

Which other funds hold AVLN?

Other major institutional holders of AVLN include Novo Holdings A/S, SR ONE CAPITAL MANAGEMENT, LP, PERCEPTIVE ADVISORS LLC, among 113 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.